Anomaly Detection in Host Signaling Pathways for the Early Prognosis of Acute Infection. by Wang, Kun et al.
UC Riverside
UC Riverside Previously Published Works
Title
Anomaly Detection in Host Signaling Pathways for the Early Prognosis of Acute Infection.
Permalink
https://escholarship.org/uc/item/9840p7hn
Journal
PloS one, 11(8)
ISSN
1932-6203
Authors
Wang, Kun
Langevin, Stanley
O'Hern, Corey S
et al.
Publication Date
2016
DOI
10.1371/journal.pone.0160919
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
RESEARCH ARTICLE
Anomaly Detection in Host Signaling
Pathways for the Early Prognosis of Acute
Infection
KunWang1,2☯, Stanley Langevin3☯, Corey S. O’Hern2,4, Mark D. Shattuck2,5,
Serenity Ogle7, Adriana Forero3, Juliet Morrison3, Richard Slayden6, Michael G. Katze3,
Michael Kirby1,8☯*
1Department of Mathematics, Colorado State University, Fort Collins, CO, United States of America,
2Department of Mechanical Engineering & Materials Science, Yale University, New Haven, CT, United
States of America, 3Department of Microbiology, School of Medicine, University of Washington, Seattle, WA,
United States of America, 4Department of Applied Physics, Department of Physics, and Graduate Program
in Computational Biology & Bioinformatics, Yale University, New Haven, CT, United States of America,
5Department of Physics and Benjamin Levich Institute, The City College of the City University of New York,
New York, NY, United States of America, 6 Department of Microbiology, Immunology and Pathology,
Colorado State University, Fort Collins, CO, United States of America, 7 Department of Biomedical Sciences,
Colorado State University, Fort Collins, CO, United States of America, 8 Department of Computer Science,
Colorado State University, Fort Collins, CO, United States of America
☯ These authors contributed equally to this work.
*Michael.Kirby@Colostate.edu
Abstract
Clinical diagnosis of acute infectious diseases during the early stages of infection is critical
to administering the appropriate treatment to improve the disease outcome. We present a
data driven analysis of the human cellular response to respiratory viruses including influ-
enza, respiratory syncytia virus, and human rhinovirus, and compared this with the
response to the bacterial endotoxin, Lipopolysaccharides (LPS). Using an anomaly detec-
tion framework we identified pathways that clearly distinguish between asymptomatic and
symptomatic patients infected with the four different respiratory viruses and that accurately
diagnosed patients exposed to a bacterial infection. Connectivity pathway analysis compar-
ing the viral and bacterial diagnostic signatures identified host cellular pathways that were
unique to patients exposed to LPS endotoxin indicating this type of analysis could be used
to identify host biomarkers that can differentiate clinical etiologies of acute infection. We
applied the Multivariate State Estimation Technique (MSET) on two human influenza
(H1N1 and H3N2) gene expression data sets to define host networks perturbed in the
asymptomatic phase of infection. Our analysis identified pathways in the respiratory virus
diagnostic signature as prognostic biomarkers that triggered prior to clinical presentation of
acute symptoms. These early warning pathways correctly predicted that almost half of the
subjects would become symptomatic in less than forty hours post-infection and that three of
the 18 subjects would become symptomatic after only 8 hours. These results provide a
proof-of-concept for utility of anomaly detection algorithms to classify host pathway signa-
tures that can identify presymptomatic signatures of acute diseases and differentiate
between etiologies of infection. On a global scale, acute respiratory infections cause a
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The development of clinical diagnostic tools to distinguish between acute viral and bacterial
respiratory infections is critical to improve patient care and limit the overuse of antibiotics in
the medical community. The identification of prognostic respiratory virus biomarkers pro-
vides an early warning system that is capable of predicting which subjects will become
symptomatic to expand our medical diagnostic capabilities and treatment options for acute
infectious diseases. The host response to acute infection may be viewed as a deterministic
signaling network responsible for maintaining the health of the host organism. We identify
pathway signatures that reflect the very earliest perturbations in the host response to acute
infection. These pathways provide a monitor the health state of the host using anomaly
detection to quantify and predict health outcomes to pathogens.
Introduction
Upon infection, human pathogens (bacteria, fungi, parasites, and viruses) induce a complex cas-
cade of host responses that have evolved to detect the pathogen and minimize the disease sever-
ity [1]. This multicellular signaling network is triggered by pathogen-specific motifs and
intracellular perturbations that activate/recruit host immune cells to infected sites and induce
cell death of infected cells. The host’s ability to sense and control pathogen replication is primar-
ily accomplished by the immune system. Both the innate and adaptive immune response to a
particular infectious agent is deliberate and dictated by a carefully orchestrated sequence of host
signaling networks. By characterizing the pathogen-specific host signaling networks and the
timing at which the pathways activate following infection, host-derived clinical assays could be
developed to augment current medical diagnostic capabilities for acute infectious diseases.
Early diagnosis of an acute infection is critical to quickly select the appropriate medical
intervention for optimum patient care and improve the overall disease outcome. While most
clinical diagnostic assays rely on pathogen detection, advances in technologies (e.g. sequencing,
microarrays, mass spec.) to measure the host response to infection provide a wealth of data
that can be exploited to improve infectious disease diagnostics [2]. Despite the efforts of many
groups for over a century, the search for host-derived biomarkers indicative of infection has
remained elusive. Recent studies have successfully applied host gene expression and proteomics
data sets to identify host conical pathways and/or individual genes associated with a particular
infectious disease [3–5]. Algorithms from machine learning have been increasingly used to
identify discriminative genes to characterize an organism’s biological state, see, e.g., [6–12].
However, the challenge in such studies is to bridge the gap between single genes that serve a
discriminative function from those that provide insight into the biological process of disease.
In order to enhance information that may be obtained by the analysis of single genes, path-
way-based analysis has become increasingly popular as an approach to elucidate the underlying
biological processes under investigation [13, 14]. Instead of focusing on selection of single dis-
criminative host genes associated with infection, pathways are a collection of predefined sets of
genes that are known to be involved in a particular cellular or physiologic function. By quanti-
fying the gene expression levels within a particular pathway, the pathway-based methods select
and rank the pathways most associated with the disease state to improve the accuracy of the
host genes defined by the computational analysis and the biological interpretation of the
results. Several pathway analytics have been developed to identify host-signaling networks for
biological states classification and prognosis. For example, in one influenza study, the top 100
Early Prognosis of Acute Infection
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discriminatory genes can be removed from the analysis without a drop in classification accu-
racy motivating a pathway analysis involving the top 1500 genes [15].
In this study we investigate the human cellular response to infection by treating the changes
in gene expression as a problem in anomaly detection. Healthy individuals are assumed to be
in a homeostatic state with immune systems that are expressing nominally while individuals
who are becoming sick possess a cascade of pathways that reflect the systematic response to a
specific invading pathogen. Our goal was to elucidate pathway-based signatures that may aid
in diagnosis as well as early prognosis of acute infection. We employed a pathway-based imple-
mentation of the Multivariate State Estimation Technique (MSET), a method for detecting
anomalies where the nominal data possesses substantial nonlinear structure in temporally
evolving systems [16–21]. This approach allowed us to analyze temporal data sets by detecting
host gene regulation anomalies within functional host networks during transitions between
biological states (i.e., healthy to symptomatic). Host pathways induced by exposure to a partic-
ular infectious agent are ranked based on predictive accuracy and then pathways that highly
correlate with the disease state are ranked according to when they deviate from a healthy base-
line state. By incorporating the temporal dimension in our pathway analysis model, we have
constructed an approach that identifies early host signaling pathways or clinical biomarkers for
diagnosing acute infectious diseases and for predicting the disease outcome.
We evaluated the anomaly detection approach using temporal gene expression data sets to
identify early host functional pathways associated with acute respiratory infections in humans.
Acute respiratory disease is a common diagnosis in clinical settings and a major cause of mor-
tality worldwide [22]. The high prevalence of bacteria and virus species that contribute to the
global respiratory disease burden combined with a significant rate of respiratory related co-
infections make the development of diagnostic tools particularly challenging. Respiratory
viruses such as influenza virus, respiratory syncytia virus, and human rhinovirus, are signifi-
cant public health threats and represent the majority of respiratory infections reported in clini-
cal settings. The rampant overuse of antibiotics in clinics to treat acute respiratory infections
has led to the emergence of antibiotic-resistant bacteria strains limiting our medical interven-
tions for pathogenic bacterial infections. The identification of host biomarkers to distinguish
between bacterial and viral respiratory infections is critical to changing this current paradigm.
We applied MSET to define host pathways associated with acute respiratory virus infection
and ranked pathways temporally to identify early host biomarkers that predict infection status
and disease outcome.
Results
In order to test and validate the methodology, we explore MSET for biological early warning
using data generated by a mathematical model of the immune system’s response to infection as
well as gene expression data sets arising in influenza and endotoxin experiments.
There are only a limited number of gene expression data sets that measure the human
immune system’s response to infection. Generally they have low temporal resolution, e.g., sam-
ples every 8 hours, but detailed gene coverage that allows us to perform a pathway based
modeling approach. Real data sets also typically have a small number of subjects [4, 5, 23]. In
contrast, the numerical simulations of virtual patients can generate finely sampled data in time
for potentially millions of subjects but, at least for the example we consider, capture only a lim-
ited number of variables. Thus the real and numerical datasets each have aspects that provide
different challenges to the algorithm.
In what follows, we first use the numerical simulation data to test MSET’s effectiveness for
the detection and prognosis of sepsis. We then proceed with a more realistic proof of concept
Early Prognosis of Acute Infection
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concerning the ability to use pathway analysis coupled with failure prediction algorithms for
early warning of a biological disease.
Early Warning on a Mathematical Model
To illustrate the performance of the early warning algorithm on a large dataset, we use a mathe-
matical model to simulate the immune system’s response to infection. The model [24]
describes the immune response in terms of the levels of pathogen P, activated phagocytes (neu-
trophils) N, tissue damage D, and anti-inflammatory mediators CA. This model consists of four
ordinary differential equations:
dP
dt
¼ kpgP 1
P
p1
 
 kpmsmP
mm þ kmpP
 kpnf ðNÞP;
dN
dt
¼ snrR
mnr þ R
 mnN;
dD
dt
¼ kdn
f ðNÞ6
x6dn þ f ðNÞ6
 mdD;
dCA
dt
¼ sc þ kcn
f ðN þ kcndDÞ
1þ f ðN þ kcndDÞ
 mcCA;
where R = f(knnN + knpP + kndD), and f ðxÞ ¼ x
1þCAc1
.
The system characterizes the time evolution of these four variables, which we view metaphor-
ically as proxies for gene expression. The model admits three final states under certain parame-
ter choices (see [24] for details): 1) Healthy (H): (P, N, D, CA) = (0, 0, 0, CA) for CA > 0, 2)
Aseptic (S0): (P, N, D, CA) = (0,N, D, CA) forN, D, CA > 0, and 3) Septic (S1): (P, N, D, CA) =
(P, N, D, CA) for all components positive.
A virtual time course experiment is performed by varying the reference parameters and the
initial conditions for P and CA in the above equations to reflect virtual subject’s variability (see
[25] for details). Here 1,000 virtual patients were generated with individualized parameter profiles
which were selected to simulate the three disease outcomes following the parameters proposed in
[25]. The proxy expression levels were measured every hour for 168 hours for each subject. Each
subject was labeled based on the final state. The distribution of final states is:H = 597, S0 = 224,
and S1 = 176. Three subjects that did not reach steady-state criteria were excluded.
For MSET analysis, the healthy data set denoted byH is equally divided into two parts ran-
domly to create the memory matrix D from training 299 points, and the test data set T0 of size
298. (Given the largely different contexts in which they occur, the reader should not confuse
the data matrix D associated with MSET and the scalar variable D representing damage in the
dynamical systems model.) The symptomatic data sets S0 and S1 serve as test data to evaluate
the model. An example simulation of a patient is shown in Fig 1. We see that the residual error
Rt in the MSET model grows quickly indicating early that this subject is becoming symptom-
atic. We observe this residual growing before 10 hours have elapsed indicating that the patient
will become septic. After 20 hours the pathogen is brought under control by the immune
response but the damage continues to increase. We emphasize that this model does not incor-
porate a therapy that would presumably be administered after the early prognosis. Table 1
shows that MSET can effectively predict disease outcome averaging 7.8 hours for S0 and 6.3
hours for S1, the most severe outcome, i.e., septic death.
The statistical measures of prognosis time, mean and standard deviation are shown in Fig 2
for both S0 and S1. The time of peak expression levels for each variable is shown for purposes of
Early Prognosis of Acute Infection
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comparison. It is interesting to observe that the MSET model outperforms any model based on
the use of a single variable using the time to peak expression. Despite the early occurrence of
damage shown in Fig 1 we see that damage is actually the slowest variable for predicting out-
comes because it takes the longest to peak. MSET predicts outcomes for patients who will
become symptomatic on the order of 6-8 hours after infection in this simulation. The pathogen
level performs best for S0 but has high standard deviation; it’s performance degrades for S1 to
Fig 1. Evaluation of MSET to detect host pathway anomalies. An example of a subject whose model goes into alarm (the
residuals Rt are indicated by the red line) providing an early indication of a symptomatic outcome. The simulated disease evolves
under the governing system of differential equations and the model goes into alarm as the pathogen (P) starts to increase
substantially in concentration. The neutrophils (N) and the damage (D) also start to grow as the system becomes anomalous.
doi:10.1371/journal.pone.0160919.g001
Table 1. MSET performance on synthetic data. Accuracy (Acc) is the percentage of subjects who are cor-
rectly identified as having the actual states. Prognosis Time (Time) is calculated based on correctly identified
subjects. Only true positive (actual disease) subjects can have meaningful prognosis time.
Data Acc(%) Time (h)
T0 99.3
S0 93.3 7.8
S1 100 6.3
doi:10.1371/journal.pone.0160919.t001
Early Prognosis of Acute Infection
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over 20 hours. In summary, when compared with the model variables in Fig 2, the MSET
prognosis time is consistently ahead of peak expression time. We concede that this example is
only illustrative and that peak expression time is not necessarily an optimal model for early
warning.
To underscore this point, we note that for this particular dynamical systems model for sepsis
it is possible to numerically partition the space of initial conditions into basins of attraction
that indicate the final state based solely on the initial condition without error. Hence, for this
given model we can do optimal early warning trivially at t = 0 in the sense that the initial condi-
tion information alone contains enough information to predict final outcome. However, in
general it is not possible to establish these basins of attraction for higher dimensional systems,
or in the presence of noise establishing a need for alternative methods for early warning such
as the one advocated here.
Fig 2. Statistical parameters for MSET analysis. The statistical measures of prognosis time (MSET) and peak expression time in
the simulated model variables pathogen (P), neutrophils (N) and the damage (D) for both the asceptic (S0) and septic death (S1)
parameters. MSET anomaly detection times are substantially earlier than variable peak expressions.
doi:10.1371/journal.pone.0160919.g002
Early Prognosis of Acute Infection
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Respiratory Virus Pathway Analysis
Next we apply the anomaly detection algorithmMSET to identify host cellular signaling path-
ways associated with the human immune response to infection by respiratory viruses. As proof
of concept, we interrogated four publicly available gene expression data sets obtained from
peripheral blood samples of human subjects experimentally infected with 4 different respira-
tory viruses, including 2 influenza virus strains: influenza viruses (H1N1, and H3N2), HRV
and RSV (Table 2). In each case the model captures the nominal gene expression of the healthy
state. Using these models, we identify canonical host pathways associated with the human
immune response to respiratory viruses. Previous studies observed that the gene expression
patterns for these four different virus were highly similar and implies there is an “acute respira-
tory viral” signature that is discriminative for acute respiratory infections (ARIs) [4, 5]. All sub-
jects experimentally infected with the 4 respiratory viruses developed mild respiratory
symptoms with no severe disease reported.
Classification of a Respiratory Virus Diagnostic Signature. We constructed an anomaly
detection model using MSET for each of the 511 functional pathways used in our analysis.
Each pathway model is a mapping of the identity that serves to detect any deviation from nom-
inal, or healthy, gene expression levels for each subject whose samples are evolving in time. We
expect healthy pathway expression levels will evolve into those distinctly characteristic of
symptomatic and asymptomatic individuals and the analysis will classify the differentially
expressed pathways in the context of host signaling networks. The analysis was performed on
each dataset and ranked pathways identified in all 4 datasets were used for downstream analy-
sis to identify robust early host signature biomarkers for respiratory virus infections.
Based on the average predictive accuracy score for each pathway, there were 16 top host
pathways associated with symptomatic human subjects that met the 0.7 probability cutoff
across all acute respiratory infection datasets (Table 3). Note that this accuracy measure is not
directly related to early warning but we will see that these pathways also do in fact go into
alarm early. These pathways represent key immune and cellular signaling networks associated
with acute respiratory virus infection [26, 27]. Host pathways involved in the antiviral response
(Influenza A, cytosolic DNA sensing, toll like receptor signaling, HIV/Nef), the inflammatory
response (IL22BP, IL10, IL-12, African trypanosomiasis, inflammatory bowel disease, and
TNFR1), and cell death/apoptosis response (Fas, lysosome, chemical) were identified as the
most accurate predictors to distinguish between asymptomatic and symptomatic subjects. The
top 5-ranked host pathways were IL-22BP (0.81), IL-10 (0.80), Fas (0.76), Intestinal Immune
network for IgA production (0.75), and influenza A (0.74). These pathways, except for influ-
enza A, encompass host genes expressed by pro-inflammatory immune cells (macrophages, T-
cells, NK cells) and epithelial cells [28–31]. These gene networks are associated with maintain-
ing the immune system’s homeostatic state in health and disease, primarily in the intestinal
mucosa. In addition, the MSET analysis identified the KEGG influenza A pathway that con-
tains host genes involved in the antiviral response to respiratory viruses that include early viral
Table 2. Overview of the data sets.
Dataset Asymp. Subjects Sympt. Subjects Probes Time Points
H1N1 6 9 12023 16
H3N2 6 9 12023 16
HRV 10 10 12023 14
RSV 11 8 12023 21
LPS 4 (placebo) 4 (endotoxin) 22281 6
doi:10.1371/journal.pone.0160919.t002
Early Prognosis of Acute Infection
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recognition signaling (2-5OAS/RNaseL, RIG-I, TLR7/3, and PKR) and downstream antiviral
effector signaling (MxA, OAS, IFN, IL-6, TNF).
Identification of Prognostic Respiratory Virus Pathway Signatures. The top pathways
based on diagnosis accuracy were further analyzed to identify the host signaling networks in
humans predicted to deviate first from the asymptomatic or healthy state as a result of acute
respiratory virus infection (Fig 3). Of central interest in this investigation are the pathways that
detect anomalies on the symptomatic subjects across all four respiratory virus data sets. We
determined 8 host signaling networks out of 511 pathways that alarm on at least half of the
symptomatic subjects. The potential early warning pathways identified were KEGG inflamma-
tory bowel disease, KEGG toll-like receptor signaling, KEGG Influenza A, KEGG lysosome,
KEGG intestinal immune network for IgA production, BIOCARTA Biopeptides, BIOCARTA
HIVNEF, and KEGG NF-kappa B signaling.
The top host signaling pathway, lysosome, is a cellular network involved with immune sens-
ing of non-self or foreign entities in the host and is utilized by respiratory viruses to infect cells.
The inflammatory bowel disease (IBD) pathway is reported in the other analyses was identified
as a potential early biomarker and contains genes that influence immune system dysregulation
of the mucosa, early TLR signaling, T-cell differentiation, and pro-inflammatory macrophage
responses. The influenza A and TLR receptor pathways encompass gene sets that regulate host
viral sensing and the antiviral response to acute respiratory virus infection in humans. The
intestinal immune network for IgA production pathway plays a role in host-microbe interac-
tion making it a natural site for the first detection of infection [31]. The top host pathways that
had the lowest probability to signal first, IL22BP and IL10, are functional networks that regu-
late inflammatory responses and promote anti-inflammatory states. Both pathways have been
shown to influence influenza virus disease severity and are associated with lung epithelial repair
following influenza induced tissue damage [32, 33].
Table 3. Signaling Pathways selected by MSET based on the baseline (pre-inoculation) samples used
as the nominal training data. The top pathways are selected based on the average MSET validation T0
accuracy (Acc), i.e., the percentage of subjects whose true state agree with the predicted model state. Here,
only the pathways which have validation accuracy above 0.70 for all four selection in Table 5 are shown. The
average MSET test T1 percentage accuracy for each pathway is also shown. The standard deviation (std) is
also given. Pathways not identified as BIOCARTA are KEGG pathways.
Rank Pathway (number of genes) T0 Acc (std) T1 Acc (std)
1 BIOCARTA IL22BP (14) 0.81 (0.05) 0.81 (0.06)
2 BIOCARTA IL10 (16) 0.80 (0.03) 0.77 (0.03)
3 BIOCARTA FAS (30) 0.76 (0.03) 0.76 (0.10)
4 Intestinal Immune Network IgA (42) 0.75 (0.03) 0.76 (0.08)
5 Inﬂuenza A (160) 0.74 (0.02) 0.74 (0.13)
6 African Trypanosomiasis (35) 0.74 (0.04) 0.76 (0.04)
7 Inﬂammatory Bowel Disease (IBD) (62) 0.74 (0.03) 0.68 (0.10)
8 Cytosolic DNA Sensing (51) 0.74 (0.02) 0.77 (0.10)
9 BIOCARTA Biopeptides (40) 0.74 (0.03) 0.75 (0.09)
10 Lysosome (114) 0.73 (0.04) 0.71 (0.10)
11 BIOCARTA Chemical (21) 0.73 (0.04) 0.70 (0.04)
12 Toll Like Receptor Signaling (99) 0.73 (0.03) 0.73 (0.07)
13 BIOCARTA IL12 (21) 0.73 (0.04) 0.73 (0.16)
14 NF-kappa B signaling (85) 0.73 (0.02) 0.72 (0.12)
15 BIOCARTA HIVNEF (56) 0.72 (0.02) 0.71 (0.08)
16 BIOCARTA TNFR1 (29) 0.71 (0.01) 0.69 (0.07)
doi:10.1371/journal.pone.0160919.t003
Early Prognosis of Acute Infection
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The performance of these pathways as early warning mechanisms for human subjects
exposed to the H1N1 or the H3N2 influenza virus strain is shown in (Fig 4). The cumulative
prognosis time distribution for a given pathway measures the accumulated fraction of the
symptomatic subjects for whom this pathway is in the alarm state as a function of time. We
note that the onset of symptoms is about the 48-60 hour range after insult while the early warn-
ing pathways suggest that almost half of the subjects will become symptomatic in less than
forty hours. In fact, this is the prognosis for three subjects after only 8 hours when we use a
combined criterion that triggers early warning if any of the 8 pathways are in alarm. We
observe approximately 20 hours separation when comparing the two earliest pathways (lyso-
some and inflammatory bowel disease) with the two slowest pathways (IL-22BP and IL-10)
selected from the 8 most accurate pathways.
It is interesting to further examine the explicit time-dependent behavior of the pathway
models more closely. We applied the toll like receptor anomaly detection model to determine
the prognosis for both an asymptomatic subject (A) and a symptomatic subject (B). The toll
like receptor pathway did not detect an anomaly for the subject who remains asymptomatic
Fig 3. Determination of early warning pathways. The probability that each selected signaling pathway will detect the anomalous status
first as computed from the test data. The signaling pathways are ranked (x-axis) based on Table 3. For example, pathway 10, KEGG
Lysosome, ties or beats the other pathways over 75% of the time.
doi:10.1371/journal.pone.0160919.g003
Early Prognosis of Acute Infection
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while, in contrast, this pathway shows a clear anomaly for the symptomatic subject some forty
hours after infection (Fig 5). We measured the response of the subset of most accurate diagnos-
tic pathways, again for both an asymptomatic and symptomatic subject (Fig 6). Although the
asymptomatic subject does feel somewhat unwell, as indicated by the Jackson Score, none of
the most accurate pathways are in alarm. In contrast, these pathways all alarm in unison some
12 hours before the symptomatic subject begins to feel significantly ill. These results suggest
that temporal pathway measurements can be exploited to monitor the host network response
to respiratory virus infection.
Anomaly detection of host pathways associated with endotoxin
exposure
In order to detect host pathway anomalies associated with an endotoxin or bacterial infection
we analyzed host response data sets that studied the acute inflammatory and immune response
to understand the mechanism of LPS response over time between the endotoxin-treated and
control groups [23, 34]. By analyzing changes in blood gene expression patterns in response to
Fig 4. Cumulative prognosis time. The cumulative prognosis time distribution for a given pathway is the accumulated fraction of the
symptomatic subjects for whom this pathway is in the alarm state as a function of time. The combined cumulative prognosis time
measures the fraction of subjects who have had one or more pathways in alarm on or before the time in hours.
doi:10.1371/journal.pone.0160919.g004
Early Prognosis of Acute Infection
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Fig 5. Evolution of the toll like receptor pathway residuals. The evolution of the toll like receptor pathway
residuals for both an asymptomatic (A) and symptomatic (B) subject. When the residual level exceeds that critical
threshold the pathway is deemed to be in alarm, indicating a response by the immune system to infection. The
irregular score is the computed χ2 value of the residuals of the MSETmodel, and if it exceeds the threshold then the
pathway is deemed to be in alarm.
doi:10.1371/journal.pone.0160919.g005
Early Prognosis of Acute Infection
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Fig 6. Temporal distribution of the respiratory virus pathway signature. The evolution of the most accurate
pathways for predicting the development of symptoms for both an asymptomatic (A) and symptomatic (B)
subject. The Jackson scores are a measure of how well the patient self reports his or her level of discomfort. The
symptomatic subjects have all of our early warning pathways in alarm by 40 hours while these pathways behave
nominally for the asymptomatic subjects.
doi:10.1371/journal.pone.0160919.g006
Early Prognosis of Acute Infection
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the inflammatory stimulus, the study reveals that the human blood leukocyte response to an
acute systemic inflammation includes the transient dysregulation of leukocyte bioenergetics
and modulation of its translational machinery. The dataset has 4 treated and 4 placebo subjects
(see Table 2). We selected two of the four control subjects to create memory matrix. The
remaining 6 subjects (2 placebo and 4 treated) were used as test data. Thus 6 MSET experi-
ments in total were performed in this study. To obtain consistent results, the signaling path-
ways were selected as having consistent classification ability, and no misclassification for all 6
MSET experiments. There were numerous host pathways that ranked with high specificity and
sensitivity using the MSET approach (Table 4). A total of 13 host pathways classified the cellu-
lar response to the endotoxin exposure in humans. The top 5 ranked pathways that distin-
guished endotoxin treated from healthy subjects with 100% accuracy were KEGG African
Trypanosomiasis (1.00), KEGG Lysine Biosynthesis (1.00), BIOCARTA LYM (1.00), BIO-
CARTA SPPA (1.00), and BIOCARTA CDMAC (1.00). These pathways encompass cellular
components responsible for pro-inflammatory responses, the recruitment of lymphocytes,
blood platelet activation, and the proliferation of leukocytes, primarily macrophages. The acti-
vation of TLR4 has been shown to mediate the immune response to LPS and this host receptor
induces a strong pro-inflammatory state by stimulating a classical M1 macrophage upon
induction [35]. The top ranked endotoxin pathways identified in our MSET analysis represent
host responses associated with an acute endotoxin exposure in humans mimicking a bacterial
infection. Due to the rapid induction of host gene expression profiles in humans exposed to
LPS, our MSET analysis detected anomalies all 13 endotoxin pathway classifiers in exposed
subjects within 2.5 hours. These results show an immediate and robust host response to endo-
toxin exposure that is primarily driven by TLR4 mediated activation of immune cells in the
blood. Interestingly, PECAM1 has been shown to regulate TLR4 signaling, preventing an
excessive immune response and therefore possible damage [36]. It has also been shown in
other studies that IL8, VCAM1, and ICAM1, which are other genes found in the LYM pathway,
are induced by LPS. This too explains the anomalous expression of the LYM pathway induced
by LPS [35]. IFNG and TNF, which are both found in the TID pathway, are shown to be
induced by LPS [37–39]. This may explain the anomalous expression of this pathway.
HSPA1A, also found in the TID pathway, seems to have a negative regulatory effect on pro-
Table 4. Signaling Pathways selected by MSET based on an exhaustive study. The performances are
presented as mean (standard deviation). The pathways are sorted based on the average time to alarm.
Pathway (number of genes) Time (h)
KEGG African Trypanosomiasis 2.00 (0.00)
KEGG Lysine Biosynthesis 2.00 (0.00)
BIOCARTA LYM 2.00 (0.00)
BIOCARTA SPPA 2.00 (0.00)
BIOCARTA CDMAC 2.00 (0.00)
BIOCARTA CBL 2.00 (0.00)
BIOCARTA P35ALZHEIMERS 2.00 (0.00)
BIOCARTA PML 2.00 (0.00)
BIOCARTA TEL 2.00 (0.00)
BIOCARTA SARS 2.00 (0.00)
KEGG Thiamine Metabolism 2.08 (0.41)
BIOCARTA IL22BP 2.08 (0.41)
BIOCARTA MONOCYTE 2.33 (0.76)
BIOCARTA IL3 2.42 (0.83)
doi:10.1371/journal.pone.0160919.t004
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inflammatory cytokine production induced by LPS, suggesting it may play an important role in
limiting an excessive immune response [40]. Finally, it has been suggested that JAK2 may be
involved in the induction of LPS induced septic shock. This is because removal of JAK2 pre-
vents septic shock from occurring [41]. In addition, the IL10 pathway plays a major role in the
regulation of inflammatory cytokines in order to limit an excessive immune response. Expres-
sion of IL10 is shown to be induced by LPS through activation of TLR4 [42]. It is suggested
that IL10 is able to specifically control production of the early effectors of endotoxic shock
such as TNF [43]. It has been found that mice without the PML gene are resistant to LPS
induced septic shock, suggesting that the PML gene plays a role in the response to LPS [44].
P53 may be important for the down regulation of response to LPS as the lack of P53 causes a
higher production of pro-inflammatory cytokines to be produced [45]. CREBBP is known to
be activated by LPS and can also be found in this pathway [46]. Finally, DAXX, a component
of the PML pathway known for its role in apoptosis, is upregulated by LPS [47]. TLR4 is
known to induce pro and anti-inflammatory cytokines in response to LPS [48]. CD13 in the
SARS pathway has been shown to response to LPS and regulate TLR4 [49, 50]. NCL has also
been shown to regulate the inflammation of alveolar macrophages induced by LPS [51].
Finally, GPT in the SARS pathway, is increased by LPS [52]. LPS regulates CD44 expression
and stimulates endothelial cells to express SELE and SELP in MONOCYTE pathway [53–55].
IL22 in the IL22BP pathway, CBL in the CBL pathway, and IL3 in the IL3 pathway, are also
induced by LPS [56–58].
Host pathway signatures to distinguish acute viral versus bacterial
infections in humans
We compared the top ranked pathway signatures generated from the 4 respiratory virus and
endotoxin datasets to determine if our MSET pathway results could be used to differentiate
between an acute bacterial and viral infection. The host pathway signatures defined by our
analysis represent distinct cellular and immune signaling networks that show little overlap as
far as biological function. Only two pathways, BIOCARTA IL-22BP and KEGG African Try-
panosomiasis, were predicted in both the endotoxin (n = 13) and respiratory virus pathway sig-
natures (n = 16). Affiliation networks demonstrated that the viral and bacterial pathways are
connected and the majority of pathways share a subset of genes with at least one other pathway
(Fig 7). Two bacterial pathways, Lysine biosynthesis and Thiamine metabolism, possessed
unique gene sets that represent potential targets for differential diagnosis between viral and
bacterial respiratory infections. Further analysis of the 526 respiratory virus vs. the 249 bacte-
rial genes within these pathway signatures showed only 12.2% are commonly shared between
the two pathogen signatures (Fig 7). These genes are directly involved in innate immune sens-
ing (TLR, MYD88, JAK/STAT), and inflammation (IL-6, IFN, TNF, IL-10, IL-22) which are
two common host signaling pathways activated by bacteria and viruses during acute respira-
tory infections. The vast majority of host genes found in the host pathway signatures were
unique to the respiratory virus and endotoxin acute responses in humans (84% virus and 66%
bacteria) providing a plethora of gene sets to evaluate for clinical differential diagnostic assays.
Materials and Methods
Data Overview
Here we describe the data sets used to illustrate the concept of early warning via anomaly detec-
tion of the immune response to infection. The first data set is generated by a numerical simula-
tion of the immune system. We also consider three microarray data sets, four associated with
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Fig 7. Evaluation of viral and bacterial signature redundancy.Weighted affiliation networks were
generated to evaluate the gene redundancy across biological pathways that distinguish viral and bacterial
signatures (A). Each node represents a pathway. Blue nodes denote viral-specific pathways and green
nodes represent bacterial-specific pathways. Edges represent the connection between pathways based on
the number of genes shared amongst each pathway. Edges are weighed on the basis of shared genes
between pathways. The ratio of overlap between networks was evaluated and represented in the heat-map
(B). Virus-specific pathways are denoted in black and bacterial-specific pathways are denoted in red in both
the column and row labels.
doi:10.1371/journal.pone.0160919.g007
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respiratory viruses and one with endotoxin. We begin with a numerical simulation of the acute
inflammatory response to pathogenic infection, i.e., sepsis, and generate illustrative data for
this study [24, 59]. This model describes the generic response of the immune system to infec-
tion as captured by four bulk variables, i.e., pathogen level, neutrophils to capture inflamma-
tion, cytokines as a proxy for anti-inflammation and damage to tissue as a consequence of the
immune response. This model based approach allows us to generate enough synthetic data to
test and validate our early warning approach. In contrast to the other problems we explore, this
study is data rich.
Transcriptomics Data. We examine five microarray data sets from the literature that were
collected in association with disease challenges with human subjects as summarized in Table 2.
We analyze four data sets associated with symptomatic respiratory viral infections in addition
to an LPS experiment.
• H1N1: TheH1N1 microarray experiment consists of 24 human subjects inoculated with
influenza A (A/Brisbane/59/2007) [4]. There were 9 subjects that were excluded due to the
indetermination. Thus the H1N1 dataset includes 9 subjects who developed symptoms and 6
subjects classified as asymptomatic.
• H3N2: TheH3N2 microarray experiment consists of 17 human subjects inoculated with
influenza A (A/Wisconsin/67/2005) [5]. Two subjects were excluded due to the indetermina-
tion. The H3N2 dataset has 9 symptomatic and 6 asymptomatic subjects.
• HRV: The HRVmicroarray experiment consists of 20 human subjects inoculated with Rhi-
novirus (HRV) serotype 39 [5]. The HRV dataset includes 10 subjects who developed symp-
toms and 10 subjects classified as asymptomatic.
• RSV: The RSVmicroarray experiment consists of 20 human subjects inoculated with respira-
tory syncytial virus (RSV) serotype A [5]. One subject had late symptoms and uninterpret-
able culture data and was excluded. Thus the RSV dataset includes 8 subjects who developed
symptoms and 11 subjects classified as asymptomatic.
For both H1N1 and H3N2, the actual time points are -5, 0, 5, 12, 21.5, 29, 36, 45.5, 53, 60,
69.5, 77, 84, 93.5, 101, 108 hours. For HRV, peripheral blood was taken at baseline, then at 4
hour intervals for the first 24 hours, then 6 hour intervals for the next 24 hours, then 8 hour
intervals for the next 24 hours, and then 24 hour intervals for the remaining 3 days of the
study. 14 time points were found in the original data set without actual time provided. For
RSV, peripheral blood was taken at baseline, then at 8 hour intervals for the initial 120 hours,
and then 24 hours for the remaining 2 days of the study. 21 time points were found in the origi-
nal data set without actual time provided. A summary of the number of data samples associated
with data set is provided in Table 5. All subjects had peripheral blood samples taken prior to
inoculation with virus (baseline), and at set intervals following inoculation. All four datasets
Table 5. Overview of the influenza datasets analysis. The baseline samples are less than validation sam-
ples because of missing baselines measures. For validation and test columns, the number of asymptomatic
(asy) subjects and the number of symptomatic (sym) are also shown. And each subject has samples collected
at set intervals after inoculation.
Selection Baseline D Validation T0 (asy/sym) Test T1 (asy/sym)
H1N1, H3N2, HRV 47 50 (22/28) 19 (11/8)
H3N2, HRV, RSV 50 54 (27/27) 15 (6/9)
HRV, RSV, H1N1 50 54 (27/27) 15 (6/9)
RSV, H1N1, H3N2 45 49 (23/26) 20 (10/10)
doi:10.1371/journal.pone.0160919.t005
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are publicly available at: http://people.ee.duke.edu/~lcarin/reproduce.html. We investigate an
endotoxin lipopolysaccharide (LPS) microarray experiment that included 8 human subjects
[23, 34]. The gene expression levels were measured before infusion at 0 h and at 2, 4, 6, 9, and
24 h afterward. The LPS dataset consists of 4 subjects who were administered endotoxin and 4
who were administered a placebo. The LPS dataset is also publicly available at: http://www.
gluegrant.org/pubsupport/Nature_1.
Pathway Analysis Data. A collection of 511 pathways were used for the actual analysis of
the gene expression data sets. These pathways map the multivariate interactions between genes
associated with biological processes, such as metabolism, signal processing, and human dis-
eases, based on biological knowledge. The pathways included in our analysis are comprised of
• 294 KEGG pathways (www.genome.jp/kegg),
• 217 BioCarta pathways (www.biocarta.com).
Model Rational
Our hypothesis is that the immune system behaves nominally when the host is in a healthy
state. We implement an anomaly detection framework that detects temporal changes in the
evolution of a dynamic system. The assumption in the model building process is that there is
no observation of anomalous behavior, only data associated with nominal (healthy) subjects is
used for training a model function f(x(t)) where the pathway evolving in time may be viewed as
a nonlinear curve observed over T time units
x : ½0;T ! Rn
where n is the number of genes in the pathway. One approach to anomaly detection is the con-
struction of the mapping of the identity, i.e.,
f ðxðtÞÞ ¼ xðtÞ
for all points on the curve x(t) that are considered to be nominal. When this relationship fails
to be true then we conclude that there is a novelty in the data and that the system for which the
model was constructed has changed. At this point we refer to the model as being in alarm.
There are a number of approaches for constructing mappings of the identity for a given data
set, see [60] for a general discussion. In this paper we restrict our attention to the Multivariate
State Estimation Technique (MSET), a non-parametric statistical method that has been applied
to detect anomalous system behavior in temporally evolving systems [16–21]. MSET uses a
model of the system that applies under nominal operating conditions. As time evolves MSET is
used to monitor the state variables of the system and to identify deviations from the nominal
state as they occur, thus providing an early warning system for potential system failures. This
approach has been effectively applied for monitoring large physical systems such as power
plants [17] and NASA’s Space Shuttle. It is attractive for the current application given the
absence of ad hoc parameters and the simplicity with which it can be trained.
The MSET model of a system is constructed from a historic sample of nominal data. In the
current application this data will be the gene expression levels of healthy individuals. Since we
are interested in understanding the immunological response we have organized the gene
expression data by pathways. In this setting an MSET early warning system will be constructed
for each pathway. Each of these MSET pathway models can now be used to monitor the tempo-
rally evolving system and identify departures from nominal state behavior.
Each model maps the given state of the system to a new state. If the system is operating in a
nominal manner, the output of this mapping is effectively the same as the input to within some
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error tolerance. However, if the system’s operating characteristics have changed then the out-
put of this mapping will no longer satisfy this property, i.e., the output of the MSET mapping
will now deviate from the input by more than the allowed tolerance. It is standard practice with
MSET to use the Sequential Probability Ratio Test (SPRT) to detect system alarms, i.e., critical
deviations where the model is deemed to no longer apply to the system. In our application
there are not enough data points (in time) to implement this approach so we implement a chi-
square (χ2) test on the residuals as a means to identify alarm points. As the results indicate, we
found this test to be very effective for detecting anomalies, but there is no theoretical basis to
claim it is the optimal approach. Statistically significant outliers in the model residual are then
used to indicate anomalous system behavior.
Multivariate State Estimation Technique
As shown in Fig 8, the training dataD, also known as the memory matrix, consists of data col-
lected while the state of system is deemed to be operating under nominal conditions. In this appli-
cation the gene expression samples are collected from healthy individuals and organized by
pathway, so there will be a memory matrix associated with the temporal evolution of each path-
way state. Specifically, the data D associated with a given pathway is a p × nmatrix that defined as
D ¼ ½xðt1Þ;    ; xðtiÞ;    ; xðtMÞ; ð1Þ
where x(ti) is a p-dimensional vector measurement of a healthy state at time ti. The value p is the
number of genes in the given pathway and will vary amongst pathways. The valueM is the total
number of healthy data states available for building the model. The expression levels of the p
genes in a given pathway encode a component of the subject’s biological state. Thus the vector
x(ti) consisting of the measurements of the p genes expression levels reﬂect the biological state of
that pathway at time ti.
Each MSET pathway model is effectively a monitoring system that detects deviations in the
gene expression patterns from the ideal healthy state. New measurements of gene expression
levels, denoted by yobs, are mapped by MSET to model estimated states yest. As described below,
if yobs yest then we conclude that the system is operating under nominal conditions.
The MSET mapping used to detect novelty is based on the construction of similarity opera-
tor in terms of the memory matrix D as [16–18]:
yest ¼ DðDT  DÞ1ðDT  yobsÞ; ð2Þ
where the matrix DT D is called a similarity matrix.
The notation is used here as a nonlinear operator that takes two matrices to produce a
new matrix; it should not be confused with the more standard use of this notation for tensor
product. It is defined component-wise as
sðXðiÞ;Y ðjÞÞ ¼ ðXT  YÞij
where the function s encodes the similarity X(i) and Y(j), i.e., the ith and jthe columns of X and
Y, respectively. If we take
sðXðiÞ;Y ðjÞÞ ¼ ðXðiÞÞTY ðjÞ
then the similarity amounts to the usual correlation and the MSET mapping is a projection
onto the space spanned by the data. However, as proposed in [16], if one takes
sðXðiÞ;Y ðjÞÞ ¼ 1 jj X
ðiÞ  Y ðjÞ jj
jj XðiÞ jj þ jj Y ðjÞ jj
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then the resulting matrix XT Y is a nonlinear measure of the similarity between X and Y. We
note that while this measure has proven very effective, there are a variety of options that can be
explored [16]. The vector DT yobs measures the similarity of a given observation yobs with
each nominal sample x in the memory matrix D. It is easy to see that the MSET mapping acts
as the identity mapping, i.e., maps a point to the identical point, on the observations that make
up D. This is a consequence of the fact that
D ¼ DðDT  DÞ1ðDT  DÞ; ð3Þ
which if we isolate a column of Dmeans
XðiÞ ¼ DðDT  DÞ1ðDT  XðiÞÞ: ð4Þ
In other words, X(i) gets mapped to itself.
Fig 8. Schematic diagram. A schematic diagram of pathway-based anomaly detection for dynamic analysis using Multivariate State
Estimation Technique [20]. The data is split into a training set which are used to build the model and a testing set which is used to validate
it. When the model fails to describe the new data, the residuals become large and an anomaly is detected.
doi:10.1371/journal.pone.0160919.g008
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For a newly observed state that shares similarities with the observations that make up the
columns of D, the difference, or residual, between the estimate and observation is relatively
small. Here the difference between a actual observation yobs and its estimate yest, i.e., the resid-
ual ry, is defined as
ry ¼ yobs  yest: ð5Þ
The residual ry is used as a signal to detect outliers for MSET. We assume that this vector of
residuals is a sample of an independent and identically distributed (i.i.d.) random multivariate
variable. For an observed state that is not similar to the columns of D, i.e., it contains some sig-
nificant novelty, the residual is larger and the assumption that it is governed by an i.i.d. normal
distribution no longer holds.
For all observations from the test data Tobs, the estimates Test are calculated using the mem-
ory matrix D by Eq 2. The test residuals RT = Tobs − Test are then obtained by Eq 5. The test
residuals RT represent the deviation of the system under test from its healthy operating condi-
tion D and are called actual residuals.
The outliers describe the abnormal data behavior, i.e., anomalous observations which are
deviating from the normal data variability. Here, the standard outlier detection method, chi-
square (χ2) test, is applied to detect the anomalous observations.
Algorithm Implementation
For each data set we construct a model based on using a subset of nominal data, i.e., data that is
assumed to be taken from subjects whose immune system is not responding to an infection.
We partition each data set into subsets of sizem and n, associated with either symptomatic and
asymptomatic subjects, respectively. Further, the data are measured at the discrete time points
labeled {t1, t2,   , tM}. The data is divided into two groups, one for training the models of size
nh, and one for testing the models, as shown in Fig 8. We note that only nominal data associ-
ated with healthy subjects sampled at baseline (t = −5) is used to train the models. The memory
matrix Dk defined in Eq (1) associated with the kth pathway is constructed from the microarray
data from the nh healthy subjects selected at random and thus has size pk × nh. Given there are
n − nh healthy test subjects andm symptomatic test subjects not in the training data set, the
test data matrix for the kth pathway Tk has size pk × (m + n − nh).
Using this notation the algorithm can now be summarized in five basic steps:
1. Pathway k consisting of pk genes is assembled from the available microarray data for each of
the k = 1,. . .,511 pathways under consideration. The data matrices Dk and Tk are created by
these pk gene expression levels that constitute pathway pk.
2. The test residuals RTk are calculated using Dk and Tk and the MSET mapping.
3. The mean μk and standard deviation σk for RTk are obtained to perform the χ
2 test with pk
degrees of freedom.
4. For each subject in Tk, the χ
2 values are calculated over the time course {t1, t2,   , tM}. These
are used to perform anomaly detection. If an anomaly is detected we refer to the time of
detection as the diagnosis time. A P-value of 0.005 is used as a cutoff between normal and
anomalous observations. We refer to the the χ2 value as the irregular score.
5. The performances for the selected pathway, the classification accuracy and the average diag-
nosis time are computed.
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Generation of affiliation networks and overlap evaluation
Affiliation network and overlap analysis of genes represented within the viral and bacterial-
specific biological pathways were generated using the R platform (v3.1.3). Graph adjacency
evaluation and network visualization was done using the Bioconductor package ‘igraph’
(v0.7.1) [61]. Networks were visualized utilizing a Kamada-Kawai layout [62].
Discussion
Advances in host gene expression technologies have provided a wealth of data on the host
response to infectious diseases. The large data sets generated by microarray and RNA sequenc-
ing (RNA-Seq) requires analytical tools that utilize new algorithms that can exploit the infor-
mation to derive biologically meaningful results. The current challenge is applying an
analytical tool or mathematical model to identify the critical host genes or gene networks in an
unbiased manner to develop targeted clinical diagnostic assays and host-derived therapeutics
against pathogenic microorganisms. Host pathway analysis incorporates the functional linkage
between gene sets to rapidly derived host gene signatures associated with an acute infection.
We utilized MSET, a well-known approach in the anomaly detection field, to analyze acute
respiratory virus and endotoxin gene expression datasets from exposed human subjects. Our
dynamical systems based MSET analysis incorporated the temporal dynamics of the host path-
ways, i.e. the changes in host response to infection overtime, to identify early host pathway bio-
markers associated with acute infection.
There are only a limited number of gene expression data sets publicly available that measure
the human cellular response to acute infection. Generally they have low temporal resolution,
e.g., samples every 12-24 hours, but detailed gene coverage that allows us to perform a pathway
based modeling approach. Clinical data sets with temporal sampling also typically have a small
number of subjects [4, 5, 23]. In contrast, the numerical simulations of virtual patients can gen-
erate finely sampled data in time for potentially millions of subjects, but in general capture
only a limited number of variables. Thus the experimental and simulated datasets evaluated in
this study each have aspects that provided different challenges to the proposed algorithm. This
proof of concept demonstrates the applicability of mathematical algorithms, e.g., MSET, com-
bined with tools from machine learning, to identify early changes in the host acute response to
infection with high specificity and sensitivity.
Our results suggest that the anomaly detection framework can be used effectively to objec-
tively identify key functional pathways or biomarkers that play a fundamental role in discrimi-
nating biological states such as symptomatic versus asymptomatic. The analysis provided a
ranking of the most accurate diagnostic host pathways associated with respiratory virus infec-
tion or endotoxin exposure. From these we identified the pathways with superior prognostic
properties in the sense that they alarm, i.e., display novelty first following infection with a virus
or bacteria. The top ranked respiratory virus pathways across all 4 viral datasets (IL-22BP, IL-
10, Fas, and intestinal IgA production) reveal an overall host signal generally associated with
the intestinal mucosa and homeostasis of the gut epithelium. Respiratory viruses are known to
cause gastrointestinal symptoms that are associated with direct infection of the intestinal epi-
thelial cells and through modulation of the intestinal microbiome [63]. One study has linked
early host immune activation in the gut to the efficacy of a live attenuated influenza vaccine
administered intra-nasally in mice [64]. In addition, these pathways have been associated with
immune cells (NK, T-cells) in the lung following infection with respiratory viruses [65]. Host
gene expression analysis of whole blood samples primarily represents intracellular RNA from
immune cell populations circulating in the bloodstream, so determining the tissue-specific
source(s) of the immune cells that contribute to whole blood transcriptome profile is not
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feasible. The top functional pathways identified in the endotoxin gene expression data set
(African Trypanosomiasis, Lysine Biosynthesis, LYM, SPPA) reveals host pathways involved in
amino acid metabolism, epithelial barrier integrity, and immune cell proliferation/migration.
Early differential diagnosis between bacterial and viral respiratory infections would greatly
enhance the treatment of acute respiratory infectious diseases. In this study, we defined pre-
symptomatic or early warning pathway signatures for both data sets and found these patho-
gen-specific biomarkers could distinguish between a patient infected with a bacteria (12 path-
ways) vs. a virus (8 pathways) within 24 hours post exposure. The pre-symptomatic 8 pathway
respiratory virus signature contains host-signaling networks involved with the innate antiviral
sensing, inflammation, and mucosal integrity. These functional pathways are consistent with
other studies predicting host biomarkers for respiratory diseases [66]. The pre-symptomatic 12
pathway endotoxin or pathogenic bacteria signature strongly correlates with macrophage/epi-
thelial activation and pro-inflammatory responses (M1 response) primarily driven by LPS
induced TL4 signaling [67, 68]. A more in-depth network analysis of the gene sets that define
these early warning viral and bacterial pathways revealed 441 viral-specific and 183 endotoxin-
specific genes that could be implemented into PCR-based diagnostic panel assays to distinguish
between acute human infections of viral and bacterial etiologies. Furthermore, a subset of
genes in endotoxin-specific host pathways, lysine biosynthesis and thymidine metabolism, that
did not share any overlapping genes with virus-specific host pathways. These combined path-
ways represent 22 unique bacteria associated genes that are being investigated as prognostic
host biomarkers for bacteria co-infections in respiratory virus positive patients admitted to the
clinic.
Based on the results obtained here, we feel further evaluation of the anomaly detection
approach for pathway analysis is warranted. We plan to further validate our results using other
algorithms for discovering novelties in temporally evolving biomarkers, as well as supervised
approaches for classification. By applying various anomaly detection approaches to human
gene expression data sets with temporal sampling, we can define unique host gene classifiers
that can distinguish between symptomatic (infected) and asymtomatic (uninfected) subjects.
This will also permit additional elucidation of the complex processes of the host cellular
response to infection, such as host signaling networks or functional pathways to diagnosis
patients infected with different pathogenic etiologies (bacteria, viruses, fungi and parasites). As
human data sets in response to acute infectious diseases becomes more readily accessible math-
ematical algorithms may be employed to identify host gene signatures that can predict infec-
tions in presymptomatic patients and distinguish between closely related viruses (SARS vs.
MERS) and/or at the virus strain level (Influenza H1N1 vs. H3N2) that present similar disease
manifestations. Rapid host-derived gene panels that represent pathogen-specific biomarkers
could be developed to complement PCR-based assay panels that target pathogen genomes for
more accurate clinical diagnostics of acute infectious diseases.
Author Contributions
Conceived and designed the experiments: KW SL CSOMDS RS MGKMK.
Performed the experiments: KW.
Analyzed the data: KW SLMK.
Contributed reagents/materials/analysis tools: KW SL AF MK.
Wrote the paper: KW SL MK SO.
Contributed to Fig 8: AF JM.
Early Prognosis of Acute Infection
PLOS ONE | DOI:10.1371/journal.pone.0160919 August 17, 2016 22 / 26
References
1. Mejias A, Suarez NM, Ramilo O. Detecting specific infections in children through host responses: a par-
adigm shift. Current opinion in infectious diseases. 2014; 27(3):228–235. PMID: 24739346
2. Ginsburg GS, Woods CW. The host response to infection: advancing a novel diagnostic paradigm. Crit
Care. 2012; 16(6):168. doi: 10.1186/cc11685 PMID: 23134694
3. Mei B, Ding X, Xu Hz, WangMt. Global gene expression changes in human peripheral blood after
H7N9 infection. Gene. 2014; 551(2):255–260. doi: 10.1016/j.gene.2014.08.062 PMID: 25192803
4. Woods CW, McClain MT, Chen M, Zaas AK, Nicholson BP, Varkey J, et al. A host transcriptional signa-
ture for presymptomatic detection of infection in humans exposed to influenza H1N1 or H3N2. PloS
One. 2013; 8(1):e52198. doi: 10.1371/journal.pone.0052198 PMID: 23326326
5. Zaas AK, Chen M, Varkey J, Veldman T, Hero AO III, Lucas J, et al. Gene expression signatures diag-
nose influenza and other symptomatic respiratory viral infections in humans. Cell Host & Microbe.
2009; 6(3):207–217. doi: 10.1016/j.chom.2009.07.006
6. Xing EP, Jordan MI, Karp RM. Feature selection for high-dimensional genomic microarray data. In:
ICML. vol. 1. Citeseer; 2001. p. 601–608.
7. Guyon I, Weston J, Barnhill S, Vapnik V. Gene selection for cancer classification using support vector
machines. Machine Learning. 2002; 46(1–3):389–422. doi: 10.1023/A:1012487302797
8. Yu L, Liu H. Redundancy based feature selection for microarray data. In: Proceedings of the tenth ACM
SIGKDD International Conference on Knowledge Discovery and Data Mining. ACM; 2004. p. 737–742.
9. Yeung KY, Bumgarner RE, Raftery AE. Bayesian model averaging: development of an improved multi-
class, gene selection and classification tool for microarray data. Bioinformatics. 2005; 21(10):2394–
2402. doi: 10.1093/bioinformatics/bti319 PMID: 15713736
10. Sun Y. Iterative RELIEF for feature weighting: algorithms, theories, and applications. Pattern Analysis
and Machine Intelligence, IEEE Transactions on. 2007; 29(6):1035–1051. doi: 10.1109/TPAMI.2007.
1093
11. van’t Veer LJ, Dai H, Van De Vijver MJ, He YD, Hart AA, Mao M, et al. Gene expression profiling pre-
dicts clinical outcome of breast cancer. Nature. 2002; 415(6871):530–536. doi: 10.1038/415530a
12. Wang Y, Makedon FS, Ford JC, Pearlman J. HykGene: a hybrid approach for selecting marker genes
for phenotype classification using microarray gene expression data. Bioinformatics. 2005; 21(8):1530–
1537. doi: 10.1093/bioinformatics/bti192 PMID: 15585531
13. Curtis RK, OrešičM, Vidal-Puig A. Pathways to the analysis of microarray data. Trends in Biotechnol-
ogy. 2005; 23(8):429–435. doi: 10.1016/j.tibtech.2005.05.011 PMID: 15950303
14. Khatri P, Sirota M, Butte AJ. Ten years of pathway analysis: current approaches and outstanding chal-
lenges. PLoS Computational Biology. 2012; 8(2):e1002375. doi: 10.1371/journal.pcbi.1002375 PMID:
22383865
15. O’Hara S, Wang K, Slayden RA, Schenkel AR, Huber G, O’Hern CS, et al. Iterative feature removal
yields highly discriminative pathways. BMCGenomics. 2013; 14(1):832. doi: 10.1186/1471-2164-14-
832 PMID: 24274115
16. Zavaljevski N, Gross K, Wegerich S. Regularization methods for the multivariate state estimation tech-
nique (MSET). Proc MC. 1999; 99.
17. Zavaljevski N, Gross KC. Sensor fault detection in nuclear power plants using multivariate state estima-
tion technique and support vector machines. In: Proceedings; Yugoslav Nuclear Society; Institute of
Nuclear Sciences VINCA; 2001.
18. Whisnant K, Gross KC, Lingurovska N. Proactive Fault Monitoring in Enterprise Servers. In: CDES;
2005. p. 3–10.
19. Cheng S, Pecht M. Multivariate state estimation technique for remaining useful life prediction of elec-
tronic products. Parameters. 2007; 1:x2.
20. Jaai R, Pecht M, Cook J. Detecting failure precursors in BGA solder joints. In: Reliability and Maintain-
ability Symposium, 2009. RAMS 2009. Annual. IEEE; 2009. p. 100–105.
21. Thompson J, Dreisigmeyer DW, Jones T, Kirby M, Ladd J. Accurate fault prediction of BlueGene/P
RAS logs via geometric reduction. In: Dependable Systems and NetworksWorkshops (DSN-W), 2010
International Conference on. IEEE; 2010. p. 8–14.
22. Zaas AK, Garner BH, Tsalik EL, Burke T, Woods CW, Ginsburg GS. The current epidemiology and clin-
ical decisions surrounding acute respiratory infections. Trends in molecular medicine. 2014; 20
(10):579–588. doi: 10.1016/j.molmed.2014.08.001 PMID: 25201713
23. Calvano SE, XiaoW, Richards DR, Felciano RM, Baker HV, Cho RJ, et al. A network-based analysis of
systemic inflammation in humans. Nature. 2005; 437(7061):1032–1037. doi: 10.1038/nature03985
PMID: 16136080
Early Prognosis of Acute Infection
PLOS ONE | DOI:10.1371/journal.pone.0160919 August 17, 2016 23 / 26
24. Reynolds A, Rubin J, Clermont G, Day J, Vodovotz Y, Bard Ermentrout G. A reduced mathematical
model of the acute inflammatory response: I. Derivation of model and analysis of anti-inflammation.
Journal of Theoretical Biology. 2006; 242(1):220–236. doi: 10.1016/j.jtbi.2006.02.016 PMID: 16584750
25. Day J, Rubin J, Clermont G. Using nonlinear model predictive control to find optimal therapeutic strate-
gies to modulate inflammation. Mathematical Biosciences and Engineering (MBE). 2010; 7(4):739–
763. doi: 10.3934/mbe.2010.7.739
26. Morrison J, Josset L, Tchitchek N, Chang J, Belser JA, Swayne DE, et al. H7N9 and other pathogenic
avian influenza viruses elicit a three-pronged transcriptomic signature that is reminiscent of 1918 influ-
enza virus and is associated with lethal outcome in mice. Journal of virology. 2014; 88(18):10556–
10568. doi: 10.1128/JVI.00570-14 PMID: 24991006
27. Parnell GP, McLean AS, Booth DR, Armstrong NJ, Nalos M, Huang SJ, et al. A distinct influenza infec-
tion signature in the blood transcriptome of patients with severe community-acquired pneumonia. Crit
Care. 2012; 16(4):R157. doi: 10.1186/cc11477 PMID: 22898401
28. Shouval DS, Ouahed J, Biswas A, Goettel JA, Horwitz BH, Klein C, et al. Interleukin 10 receptor signal-
ing: master regulator of intestinal mucosal homeostasis in mice and humans. Adv Immunol. 2014;
122:177–210. doi: 10.1016/B978-0-12-800267-4.00005-5 PMID: 24507158
29. Nikoopour E, Bellemore SM, Singh B. IL-22, cell regeneration and autoimmunity. Cytokine. 2014;
PMID: 25467639
30. Lettau M, Paulsen M, Schmidt H, Janssen O. Insights into the molecular regulation of FasL (CD178)
biology. European journal of cell biology. 2011; 90(6):456–466. doi: 10.1016/j.ejcb.2010.10.006 PMID:
21126798
31. Gutzeit C, Magri G, Cerutti A. Intestinal IgA production and its role in host-microbe interaction. Immuno-
logical reviews. 2014; 260(1):76–85. doi: 10.1111/imr.12189 PMID: 24942683
32. Pociask DA, Scheller EV, Mandalapu S, McHugh KJ, Enelow RI, Fattman CL, et al. IL-22 is essential
for lung epithelial repair following influenza infection. The American journal of pathology. 2013; 182
(4):1286–1296. doi: 10.1016/j.ajpath.2012.12.007 PMID: 23490254
33. Sun K, Torres L, Metzger DW. A detrimental effect of interleukin-10 on protective pulmonary humoral
immunity during primary influenza A virus infection. Journal of virology. 2010; 84(10):5007–5014. doi:
10.1128/JVI.02408-09 PMID: 20200252
34. Storey JD, XiaoW, Leek JT, Tompkins RG, Davis RW. Significance analysis of time course microarray
experiments. Proceedings of the National Academy of Sciences of the United States of America. 2005;
102(36):12837–12842. doi: 10.1073/pnas.0504609102 PMID: 16141318
35. Sawa Y, Ueki T, Hata M, Iwasawa K, Tsuruga E, Kojima H, et al. LPS-induced IL-6, IL-8, VCAM-1, and
ICAM-1 expression in human lymphatic endothelium. Journal of Histochemistry & Cytochemistry. 2008;
56(2):97–109. doi: 10.1369/jhc.7A7299.2007
36. Rui Y, Liu X, Li N, Jiang Y, Chen G, Cao X, et al. PECAM-1 ligation negatively regulates TLR4 signaling
in macrophages. The Journal of Immunology. 2007; 179(11):7344–7351. doi: 10.4049/jimmunol.179.
11.7344 PMID: 18025177
37. Blanchard D, Djeu JY, Klein TW, Friedman H, Stewart W. Interferon-gamma induction by lipopolysac-
charide: dependence on interleukin 2 and macrophages. The Journal of Immunology. 1986; 136
(3):963–970. PMID: 2867114
38. Negishi M, Izumi Y, Aleemuzzaman S, Inaba N, Hayakawa S. Lipopolysaccharide (LPS)-induced Inter-
feron (IFN)-gamma Production by Decidual Mononuclear Cells (DMNC) is Interleukin (IL)-2 and IL-12
Dependent. American Journal of Reproductive Immunology. 2011; 65(1):20–27. doi: 10.1111/j.1600-
0897.2010.00856.x PMID: 20482522
39. Xaus J, Comalada M, Valledor AF, Lloberas J, López-Soriano F, Argilés JM, et al. LPS induces apopto-
sis in macrophages mostly through the autocrine production of TNF-α. Blood. 2000; 95(12):3823–3831.
PMID: 10845916
40. Shi Y, Tu Z, Tang D, Zhang H, Liu M, Wang K, et al. THE INHIBITIONOF LPS-INDUCED PRODUC-
TION OF INFLAMMATORY CYTOKINES BY HSP70 INVOLVES INACTIVATION OF THE NF-[kappa]
B PATHWAY BUT NOT THEMAPK PATHWAYS. Shock. 2006; 26(3):277–284. PMID: 16912653
41. Zhong J. Jak2 deficiency prevents mice from LPS-induced sepsis by modulating innate immunity with-
out affecting adaptive immunity through STAT5 and STAT6 pathways. The Journal of Immunology.
2009; 182:91–17.
42. Iyer SS, Ghaffari AA, Cheng G. Lipopolysaccharide-mediated IL-10 transcriptional regulation requires
sequential induction of type I IFNs and IL-27 in macrophages. The Journal of Immunology. 2010; 185
(11):6599–6607. doi: 10.4049/jimmunol.1002041 PMID: 21041726
43. Berg DJ, Kühn R, Rajewsky K, Müller W, Menon S, Davidson N, et al. Interleukin-10 is a central regula-
tor of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not
Early Prognosis of Acute Infection
PLOS ONE | DOI:10.1371/journal.pone.0160919 August 17, 2016 24 / 26
endotoxin tolerance. Journal of Clinical Investigation. 1995; 96(5):2339. doi: 10.1172/JCI118290 PMID:
7593621
44. A L, M G, M G, R R, A B, M A, et al. A role for PML in innate immunity. Genes & Cancer. 2011; 2(1):10–
19. doi: 10.1177/1947601911402682
45. Liu G, Park YJ, Tsuruta Y, Lorne E, Abraham E. p53 attenuates lipopolysaccharide-induced NF-κB acti-
vation and acute lung injury. The Journal of Immunology. 2009; 182(8):5063–5071. doi: 10.4049/
jimmunol.0803526 PMID: 19342686
46. WuCX, Sun H, Liu Q, Guo H, Gong JP. LPS induces HMGB1 relocation and release by activating the
NF-κB-CBP signal transduction pathway in the murine macrophage-like cell line RAW264. 7. Journal of
Surgical Research. 2012; 175(1):88–100. doi: 10.1016/j.jss.2011.02.026 PMID: 21571302
47. Z Y, Q Z, X L, D Z, Y L, K Z, et al. Death Domain-associated Protein 6 (Daxx) Selectively Represses IL-
6 Transcription through Histone Deacetylase 1 (HDAC1)-mediated Histone Deacetylation in Macro-
phages. Journal of Biological Chemistry. 2014; 289(13):9372–9379. doi: 10.1074/jbc.M113.533992
48. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, et al. TLR4mutations are associated
with endotoxin hyporesponsiveness in humans. Nature Genetics. 2000; 25(2):187–191. doi: 10.1038/
76048 PMID: 10835634
49. Huschak G, Zur Nieden K, Stuttmann R, Riemann D. Changes in monocytic expression of aminopepti-
dase N/CD13 after major trauma. Clinical & Experimental Immunology. 2003; 134(3):491–496. doi: 10.
1111/j.1365-2249.2003.02302.x
50. Ghosh M, Subramani J, Rahman M, Shapiro L. CD13 is a novel regulator of TLR4 endocytosis in den-
dritic cells (CAM5P. 241). The Journal of Immunology. 2014; 192(1 Supplement):180–12.
51. Wang Y, Mao M, Xu Jc. Cell-surface nucleolin is involved in lipopolysaccharide internalization and sig-
nalling in alveolar macrophages. Cell Biology International. 2011; 35(7):677–685. doi: 10.1042/
CBI20100625 PMID: 21309751
52. Kim ID, Ha BJ. The effects of paeoniflorin on LPS-induced liver inflammatory reactions. Archives of
Pharmacal Research. 2010; 33(6):959–966. doi: 10.1007/s12272-010-0620-8 PMID: 20607502
53. Gee K, LimW, MaW, Nandan D, Diaz-Mitoma F, Kozlowski M, et al. Differential regulation of CD44
expression by lipopolysaccharide (LPS) and TNF-α in humanmonocytic cells: distinct involvement of c-
Jun N-terminal kinase in LPS-induced CD44 expression. The Journal of Immunology. 2002; 169
(10):5660–5672. doi: 10.4049/jimmunol.169.10.5660 PMID: 12421945
54. Huang K, Fishwild DM, Wu HM, Dedrick RL. Lipopolysaccharide-induced E-selectin expression
requires continuous presence of LPS and is inhibited by bactericidal/permeability-increasing protein.
Inflammation. 1995; 19(3):389–404. doi: 10.1007/BF01534395 PMID: 7543076
55. Gotsch U, Jäger U, Dominis M, Vestweber D. Expression of P-selectin on endothelial cells is upregu-
lated by LPS and TNF-α in vivo. Cell Communication and Adhesion. 1994; 2(1):7–14. doi: 10.3109/
15419069409014198
56. Weber GF, Schlautkötter S, Kaiser-Moore S, Altmayr F, Holzmann B, Weighardt H. Inhibition of inter-
leukin-22 attenuates bacterial load and organ failure during acute polymicrobial sepsis. Infection and
immunity. 2007; 75(4):1690–1697. doi: 10.1128/IAI.01564-06 PMID: 17261606
57. Scholz G, Cartledge K, Dunn AR. Hck enhances the adherence of lipopolysaccharide-stimulated mac-
rophages via Cbl and phosphatidylinositol 3-kinase. Journal of Biological Chemistry. 2000; 275
(19):14615–14623. doi: 10.1074/jbc.275.19.14615 PMID: 10799548
58. Tuyt LM, DeWit H, Koopmans SB, Sierdsema SJ, Vellenga E. Effects of IL-3 and LPS on transcription
factors involved in the regulation of IL-6 mRNA. British Journal of Haematology. 1996; 92(3):521–529.
doi: 10.1046/j.1365-2141.1996.00378.x PMID: 8616012
59. Day J, Rubin J, Vodovotz Y, Chow CC, Reynolds A, Clermont G. A reduced mathematical model of the
acute inflammatory response II. Capturing scenarios of repeated endotoxin administration. Journal of
Theoretical Biology. 2006; 242(1):237–256. doi: 10.1016/j.jtbi.2006.02.015 PMID: 16616206
60. Kirby M. Geometric data analysis: an empirical approach to dimensionality reduction and the study of
patterns. New York, NY: JohnWiley & Sons, Inc.; 2000.
61. Csardi G, Nepusz T. The igraph software package for complex network research. InterJournal, Com-
plex Systems. 2006; 1695(5):1–9.
62. Kamada T, Kawai S. An algorithm for drawing general undirected graphs. Information processing let-
ters. 1989; 31(1):7–15. doi: 10.1016/0020-0190(89)90102-6
63. Openshaw P. Crossing barriers: infections of the lung and the gut. Mucosal immunology. 2009; 2
(2):100–102. doi: 10.1038/mi.2008.79 PMID: 19129753
64. Oh JZ, Ravindran R, Chassaing B, Carvalho FA, Maddur MS, Bower M, et al. TLR5-mediated sensing
of gut microbiota is necessary for antibody responses to seasonal influenza vaccination. Immunity.
2014; 41(3):478–492. doi: 10.1016/j.immuni.2014.08.009 PMID: 25220212
Early Prognosis of Acute Infection
PLOS ONE | DOI:10.1371/journal.pone.0160919 August 17, 2016 25 / 26
65. Guo H, Topham DJ. Interleukin-22 (IL-22) production by pulmonary Natural Killer cells and the potential
role of IL-22 during primary influenza virus infection. Journal of virology. 2010; 84(15):7750–7759. doi:
10.1128/JVI.00187-10 PMID: 20504940
66. Jin S, Zou X. Construction of the influenza A virus infection-induced cell-specific inflammatory regula-
tory network based on mutual information and optimization. BMC systems biology. 2013; 7(1):105. doi:
10.1186/1752-0509-7-105 PMID: 24138989
67. Derlindati E, Dei Cas A, Montanini B, Spigoni V, Curella V, Aldigeri R, et al. Transcriptomic analysis of
human polarized macrophages: more than one role of alternative activation? PloS one. 2015; 10(3):
e0119751. doi: 10.1371/journal.pone.0119751 PMID: 25799240
68. Guha M, Mackman N. LPS induction of gene expression in humanmonocytes. Cellular signalling.
2001; 13(2):85–94. doi: 10.1016/S0898-6568(00)00149-2 PMID: 11257452
Early Prognosis of Acute Infection
PLOS ONE | DOI:10.1371/journal.pone.0160919 August 17, 2016 26 / 26
